Omer Gilan
Impact in
-
- Cancer Genomics and Diagnostics
-
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 3
- CRISPR and Genetic Engineering 3
- Protein Degradation and Inhibitors 2
- TGF-β signaling in diseases 2
- Histone Deacetylase Inhibitors Research 2
- Ubiquitin and proteasome pathways 2
-
- Acute Myeloid Leukemia Research 2
- Co-authors
- Charles C. Bell (6 shared papers)Mark A. Dawson (7 shared papers)Amardeep S. Dhillon (3 shared papers)Eugene Tulchinsky (3 shared papers)Jeannine Diesch (3 shared papers)John M. Mariadason (3 shared papers)Ross D. Hannan (3 shared papers)Richard B. Pearson (2 shared papers)
- Journals
- Oncogene (2 papers)Blood (2 papers)Cancer Cell (1 paper)Nature Genetics (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Omer Gilan
13 papers receiving 361 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 92
- Hematology 46
- Molecular Biology 253
- Oncology 93
- Modeling and Simulation 14
Countries citing papers authored by Omer Gilan
This map shows the geographic impact of Omer Gilan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omer Gilan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omer Gilan more than expected).
Fields of papers citing papers by Omer Gilan
This network shows the impact of papers produced by Omer Gilan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omer Gilan. The network helps show where Omer Gilan may publish in the future.
Co-authors
The 25 scholars most cited alongside Omer Gilan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 106 | |
| 2 | 2014 | 67 | |
| 3 | 2015 | 40 | |
| 4 | 2017 | 28 | |
| 5 | 2016 | 26 | |
| 6 | 2011 | 26 | |
| 7 | 2023 | 19 | |
| 8 | 2014 | 18 | |
| 9 | 2023 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2021 | 6 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 1 |
About Omer Gilan
Omer Gilan is a scholar working on Molecular Biology, Hematology, Genetics, Immunology and Cancer Research, having authored 13 papers that have together received 362 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Genomics and Chromatin Dynamics (3 papers), CRISPR and Genetic Engineering (3 papers), Protein Degradation and Inhibitors (2 papers), TGF-β signaling in diseases (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Acute Myeloid Leukemia Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (92 citations), Hematology (46 citations), Molecular Biology (253 citations), Oncology (93 citations) and Modeling and Simulation (14 citations). Omer Gilan has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Charles C. Bell, Mark A. Dawson, Amardeep S. Dhillon, Eugene Tulchinsky, Jeannine Diesch, John M. Mariadason, Ross D. Hannan, Richard B. Pearson, Nicholas I. Fleming and Izhak Haviv. Their work appears in journals such as Oncogene, Blood, Cancer Cell, Nature Genetics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.